Effects of Allopurinol on Beer-induced Increases in Plasma Concentrations and Urinary Excretion of Purine Bases (Uric Acid, Hypoxanthine, and Xanthine)

Abstract

To determine the effects of allopurinol on beer-induced increases in plasma and urinary excretion of purine bases (hypoxanthine, xanthine, and uric acid), we performed three experiments on five healthy study participants. In the first experiment (combination study), the participants ingested beer (10 ml/kg body weight) eleven hours after taking allopurinol (300 mg). In the second experiment (beer-only study), the same participants ingested beer (10 ml/kg body weight) alone, while in the third experiment (allopurinol-only study), they took allopurinol (300 mg) alone. There was a two-week interval between each of the studies. Beer-induced increases in plasma concentration and urinary excretion of hypoxanthine in the combination study were markedly higher than those in the beer-only study. On the other hand, the sum of increases in plasma concentrations of purine bases in the beer-only study was greater than in the combination study, whereas the increase in plasma uridine concentration in the combination study did not differ from the beer-only study. In addition, allopurinol administration inhibited the beer-induced increase in plasma concentration of uric acid. These results suggest that abrupt adenine nucleotide degradation may increase plasma concentration and urinary excretion of hypoxanthine under conditions of low xanthine dehydrogenase activity, which is mostly ascribable to allopurinol. Further, the difference in the sum of increases in plasma concentrations of purine bases between the combination study and beer-only study was largely ascribable to a greater increase in urinary excretion of hypoxanthine in the combination study. In addition, allopurinol intake seems to be effective in controlling the rapid increase in plasma uric acid caused by ingestion of alcoholic beverages.

Key words

Uric acid - hypoxanthine - xanthine - allopurinol - beer

References

• 1 Lieber C S. Hyperuricemia induced by alcohol.  Arthritis Rheum. 1965;  8 786-798
• 2 Faller J, Fox I H. Ethanol-induced hyperuricemia: evidence for increased urate production by activation of adenine nucleotide turnover.  N Engl J Med. 1982;  307 1598-1602
• 3 Puig J G, Fox I H. Ethanol-induced activation of adenine nucleotide turnover. Evidence for a role of acetate.  J Clin Invest. 1984;  74 936-941
• 4 Gibson T, Rodgers A V, Simmonds H A, Toseland P. Beer drinking and its effect on uric acid.  Br J Rheumatol. 1984;  23 203-209
• 5 Nishioka K, Sumida T, Iwatani M, Kusumoto A, Ishikura Y, Hatanaka H, Yomo H, Kohda H, Ashikari T, Shibano Y, Suwa Y. Influence of moderate drinking on purine and carbohydrate metabolism.  Alcohol Clin Exp Res. 2002;  26 (Suppl 8) 20S-25S
• 6 Nishimura T, Shimizu T, Mineo I, Kawachi M, Ono A, Nakajima H, Kuwajima M, Kono N, Matsuzawa Y. Influence of daily drinking habits on ethanol-induced hyperuricemia.  Metabolism. 1994;  43 745-748
• 7 Yamamoto T, Moriwaki Y, Takahashi S, Suda M, Higashino K. Effect of ethanol ingestion on nucleotides and glycolytic intermediates in erythrocytes and purine bases in plasma and urine: acetaldehyde-induced erythrocyte purine degradation.  Metabolism. 1993;  42 1212-1216
• 8 Yamamoto T, Moriwaki Y, Takahashi S, Yamakita J, Tsutsumi Z, Ohata H, Hiroishi K, Nakano T, Higashino K. Effect of ethanol and fructose on plasma uridine and purine bases.  Metabolism. 1997;  46 544-547
• 9 Yamamoto T, Moriwaki Y, Takahashi S, Tsutsumi Z, Ka T, Fukuchi M, Hada T. Effect of beer on the plasma concentrations of uridine and purine bases.  Metabolism. 2002;  51 1317-1323
• 10 Yamamoto T, Moriwaki Y, Ka T, Inokuchi T, Takahashi S, Tsutsumi Z, Fukuchi M, Hada T. Effect of purine-free low-malt liquor (happo-shu) on the plasma concentrations and urinary excretion of purine bases and uridine - comparison between purine-free and regular happo-shu.  Horm Metab Res. 2004;  36 231-237
• 11 Kaneko K, Fujimori S, Ishizuka I, Akaoka I. Effect of ethanol on metabolism of the hypouricemic agents allopurinol and benzbromarone.  Clin Chim Acta. 1990;  193 181-186
• 12 Elion G B, Kovensky A, Hitchings G H. Metabolic studies of allopurinol, an inhibitor of xanthine oxidase.  Biochem Pharmacol. 1966;  15 863-880
• 13 Goldfinger S, Klinenberg J R, Seegmiller J E. The renal excretion of oxypurines.  J Clin Invest. 1965;  44 623-628